MoneyWorks4Me

Supha Pharmachem informs about board meeting

03 Feb 2026 Evaluate
Supha Pharmachem has informed that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 to consider and approve Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December, 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Supha Pharmachem Share Price

0.28 -0.01 (-3.45%)
03-Sep-2026 14:27 View Price Chart
Peers
Company Name CMP
Redington 370.05
Amrapali Industries 32.52
Adani Enterprises 2893.35
Rashi Peripheral 814.40
PDS 355.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: